ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC

September 10, 1982

In Belief: Warren Ross Named Director Of Louisville’s Brown Cancer Center; NCI Landow Offices Moved

August 5, 1988

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

Clanton Resigns From NCI.

January 12, 2007